US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Lifecore Biomedical, Inc. - Common Stock
(NQ:
LFCR
)
6.380
-0.060 (-0.93%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lifecore Biomedical, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD)
October 05, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
Halper Sadeh LLC is Investigating Whether MG, LFCR, MGLD are Obtaining Fair Deals for their Shareholders
October 04, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Halper Sadeh LLC is Investigating Whether LFCR and SSTI are Obtaining Fair Deals for their Shareholders
September 30, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCR
September 30, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Halper Sadeh LLC is Investigating Whether LFCR, MKTX, UTZ are Obtaining Fair Deals for their Shareholders
September 30, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ)
September 30, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders
September 28, 2026
From
Halper Sadeh LLC
Via
Business Wire
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCR
April 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles
January 30, 2026
From
Grabar Law Office
Via
GlobeNewswire
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your Behalf
January 28, 2026
From
Grabar Law Office
Via
GlobeNewswire
Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
January 23, 2026
From
Grabar Law Office
Via
GlobeNewswire
Notice to Long-Term Shareholders of CoreWeave, Inc. (NASDAQ: CRWV); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your Behalf
January 22, 2026
From
Grabar Law Office
Via
GlobeNewswire
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf
January 21, 2026
From
Grabar Law Office
Via
GlobeNewswire
Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
January 19, 2026
From
Grabar Law Office
Via
GlobeNewswire
Attention Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
January 16, 2026
From
Grabar Law Office
Via
GlobeNewswire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
January 15, 2026
From
Halper Sadeh LLC
Via
Business Wire
Attention Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
January 14, 2026
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your
January 12, 2026
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
January 09, 2026
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
January 08, 2026
From
Grabar Law Office
Via
GlobeNewswire
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
January 07, 2026
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your
January 05, 2026
From
Grabar Law Office
Via
GlobeNewswire
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
January 02, 2026
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf
December 31, 2025
From
Grabar Law Office
Via
GlobeNewswire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
December 07, 2025
From
Halper Sadeh LLC
Via
Business Wire
LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 27, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 14, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
April 03, 2025
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Announces Special Stockholder Meeting
January 17, 2025
Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock Terms
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
January 07, 2025
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
